MRGPRX1
Mas-related G-protein coupled receptor member X1
Also known as: MRGX1, MRGX1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LB2
- Gene
- MRGPRX1
- Ensembl
- ENSG00000170255
- Chromosome
- 11
- Canonical length
- 322 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Enables transmembrane signaling receptor activity. Involved in cell surface receptor signaling pathway and response to chloroquine. Predicted to be located in cell surface. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
322 residues, UniProt reviewed canonical sequence.
>Q96LB2|MRGPRX1
1 MDPTISTLDT ELTPINGTEE TLCYKQTLSL TVLTCIVSLV GLTGNAVVLW LLGCRMRRNA
61 FSIYILNLAA ADFLFLSGRL IYSLLSFISI PHTISKILYP VMMFSYFAGL SFLSAVSTER
121 CLSVLWPIWY RCHRPTHLSA VVCVLLWALS LLRSILEWML CGFLFSGADS AWCQTSDFIT
181 VAWLIFLCVV LCGSSLVLLI RILCGSRKIP LTRLYVTILL TVLVFLLCGL PFGIQFFLFL
241 WIHVDREVLF CHVHLVSIFL SALNSSANPI IYFFVGSFRQ RQNRQNLKLV LQRALQDASE
301 VDEGGGQLPE EILELSGSRL EQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRGPRX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 0 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
- blood vessel: 0 nTPM
Single-cell type
- syncytiotrophoblasts: 6.8 nCPM
- migrating cytotrophoblasts: 2.2 nCPM
- extravillous trophoblasts: 1.9 nCPM
- early spermatids: 0.2 nCPM
- early primary spermatocytes: 0.1 nCPM
- hofbauer cells: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- cerebellum: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- midbrain: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -0.92
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute-phase response
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- negative regulation of sensory perception of pain
- phospholipase C-activating G protein-coupled receptor signaling pathway
- sensory perception of itch
- signal transduction
- sneeze reflex
- response to chloroquine
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRGPRX1 as an antibody target. Whether an autoantibody or antibody against MRGPRX1 could matter depends on whether native MRGPRX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRGPRX1 is annotated at the cell surface, where native MRGPRX1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MRGPRX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...